Lung Cancer
AWS and App developer
October 18, 2023
Summary "Deep learning-based six-type classifier for lung cancer and mimics from histopathological whole slide images."
The development and application of deep learning techniques in the field of medical image analysis have seen significant advancements in recent years. One particularly promising area of research is the use of deep...
Graphic designer
October 04, 2023
Summary "Development of an eHealth tool for capturing and analyzing the immune-related adverse events (irAEs) in cancer treatment."
Immunotherapy is rapidly advancing and can now be considered a powerful new tool in the treatment of cancer. However, it is associated with a myriad of Immune-related adverse events (irAEs). These irAEs can affect numerous...
Content writer – Clinical
September 20, 2023
Summary "Artificial intelligence–based prediction of lung cancer risk using non-imaging electronic medical records: deep learning approach."
Lung cancer is the most common cause of death worldwide. So, early detection is crucial which may be helpful to reduce mortality rate. Low-dose computed tomography (LDCT) screening may reduce the lung cancer...
Content writer – Clinical
September 13, 2023
Summary "Clinical trial shows potential of poziotinib for HER2-mutant lung cancer."
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for up to 85% of the patients. Around 3% of these NSCLC patients have mutations in the human epidermal growth factor receptor 2...
Software engineer
September 06, 2023
Summary "An explainable machine learning framework for lung cancer hospital length of stay prediction."
The importance of predicting the length of stay (LOS) in the ICU for lung cancer patients is not well understood. This is because LOS can be used to manage hospital resources and improve patient outcomes. Traditional...
Content writer – Clinical
August 16, 2023
Summary "Easy-to-find irAEs can be used as indicators to predict neoadjuvant chemo-immunotherapy response."
Lung cancer is the prominent cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC) patients are diagnosed with early-stage disease in only 25% of cases, making them amenable to...
Content writer – Clinical
August 02, 2022
Summary "The efficacy and safety of albumin-bound paclitaxel plus carboplatin as neoadjuvant therapy for potentially resectable lung squamous cell carcinoma: a real-world retrospective cohort study."
Lung cancer is the leading cause of cancer-related death. The most frequent forms of treatment for lung cancer include chemotherapy, radiotherapy, and surgery. The most common type of lung cancer is...
Content writer – Clinical
July 12, 2023
Summary "Lung cancer prediction using robust machine learning and image enhancement methods on extracted gray-level co-occurrence matrix features."
In the present era, cancer is the leading cause of demise in both men and women world-wide, with low survival rates due to inefficient diagnostic techniques. In the year 2021, about 1,898,160 new cancer cases were...
Sr. scientist – Omics
July 05, 2023
Summary "Nivolumab therapy in addition to chemotherapy improves survival in patients with resectable lung cancer."
Lung cancer is the third most common cancer in the United States. Over 80% of the total lung cancer cases belong to the type of non-small cell lung cancer (NSCLC). Among the patients diagnosed with.
Sr. scientist – Omics
June 21, 2023
Summary "Role of air pollutants in lung cancer."
Lung cancer in never-smokers (LCINS) is the eighth most common cause of cancer death in the UK. Such patients bear distinct clinical and molecular characteristics compared to lung cancer in smokers which...
